News Releases

Valeant Pharmaceuticals To Present At The 34th Annual J.P. Morgan Healthcare Conference

LAVAL, Quebec, Jan. 4, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) today announced that members of its senior management team will present at the 34th Annual J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco, California on Wednesday, January 13, 2016 at 10:30 a.m. (1:30 p.m. ET).

A live webcast and audio archive of the presentation will be available on Valeant's corporate website on the "Investor Relations" page, under the "Events and Presentations" tab and via this URL:

Participants are encouraged to allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the webcast.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at

Contact Information:
Laurie W. Little

Elif McDonald

Renee E. Soto/Meghan Gavigan
Sard Verbinnen & Co.
212-687-8080 /

Valeant Pharmaceuticals International, Inc.

Logo -


SOURCE Valeant Pharmaceuticals International, Inc.